Bruce Booth

Bruce Booth is a Partner at Atlas Venture with extensive leadership experience as Chairman of the Board of Directors for multiple biopharmaceutical companies, including Kymera Therapeutics, Nimbus Therapeutics, Vigil Neuroscience, and Arkuda Therapeutics. Bruce Booth earned a D.Phil. in Immunology from the University of Oxford between 1996 and 1999 and holds a B.S. in Biochemistry from Penn State University, completed in 1996.